Josh Mandel-Brehm
Director/Board Member at PROMIS NEUROSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Josh Mandel-Brehm is a Director at Vico Therapeutics BV, which he founded in 2019.
He is currently the President, Chief Executive Officer & Director at Camp4 Therapeutics Corp.
since 2017 and an Independent Director at ProMIS Neurosciences, Inc. since 2021.
Mr. Mandel-Brehm completed his undergraduate degree at Washington University in St. Louis and his MBA at the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-05-04 | 0 ( -.--% ) | - $ | 2024-03-30 |
Josh Mandel-Brehm active positions
| Companies | Position | Start |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Director/Board Member | 2021-08-31 |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 2017-04-30 |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Founder | 2019-08-31 |
Training of Josh Mandel-Brehm
| Washington University in St. Louis | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Josh Mandel-Brehm
